ENST00000569074.1:n.216-12994C>A

Variant summary

Our verdict is Benign.
<-10 Benign
-7
-6
-1
0
+5
+6
+9
+10
B
LB
VUS
LP
P
The variant received -12 classification points (ACMG Germline Pathogenicity v2019). BA1BP4_Strong

The ENST00000569074.1(CASC17):n.216-12994C>A variant causes a intron, non coding transcript change involving the alteration of a non-conserved nucleotide. Note: ENST00000569074.1 is not a MANE Select or MANE Plus Clinical transcript for CASC17; the reported annotation may differ from that of the MANE-designated reference transcript for this gene. The variant allele was found at a cumulative frequency of 0.56 (AC=85,130) in the gnomAD database across 151,984 control chromosomes, including 24,465 homozygotes. The grpmax filtering allele frequency (95% CI) is 0.687. In-silico predictor (BayesDel (noAF)) classifies this variant as likely benign. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.56 ( 24465 hom., cov: 32)

Consequence

CASC17
ENST00000569074.1 intron, non_coding_transcript

Predictors

3
AlphaGenome AVI: 1 : Benign

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.163

Publications

171 publications found
Genes affected
CASC17 (HGNC:43911): ()
ENSG00000300867 (HGNC:):

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript ENST00000569074.1, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

Classification according to ACMG Germline Pathogenicity v2019

Classification was made for transcript:

Our verdict: Benign. The variant received -12 points.

BP4Computational evidence suggests no impact
Computational evidence supports benign — no pathogenic computational or splicing signal (BP4); No splicing predictor data available; Germline computational verdict: benign (Strong)
BA1Stand-alone benign allele frequency (>5%)
GnomAD effective popmax AF >5% — BA1 stand-alone benign; GnomAD reliable popmax AF = 0.6866 — exceeds 5% threshold (BA1 applied)

Variant Effect in Transcripts

Automated classification analysis was done for transcript: ENST00000569074.1. You can select a different transcript below to see updated classification assignments.

RefSeq Transcripts

CASC17 NR_104152.1
HGVSc / HGVSpn.218-12994C>A
Exon rankIntron 3 of 3
intronnon_coding_transcript
Prot:

Ensembl Transcripts

CASC17 ENST00000569074.1
TSL:1
HGVSc / HGVSpn.216-12994C>A
Exon rankIntron 3 of 3
intronnon_coding_transcript
Prot:
CASC17 ENST00000659670.1
HGVSc / HGVSpn.252-12994C>A
Exon rankIntron 3 of 3
intronnon_coding_transcript
Prot:
ENSG00000300867 ENST00000774768.1
HGVSc / HGVSpn.548+2790G>T
Exon rankIntron 2 of 2
intronnon_coding_transcript
Prot:

Frequencies

Allele frequencies (AF), counts (AC/AN), homozygotes and coverage

Common (AF > 0.05 / Hom > 5)
Rare (AF ≤ 0.0001 / Hom ≤ 1)
Global population databases 4 sources
GnomAD3 genomes
AF: 0.560
AC:85073
Hom:24444
AN:151866
Cov:32
GnomAD4 genome
AF: 0.560
AC:85130
Hom:24465
AN:151984
Cov:32
TOPMed (Bravo)
AF: 0.565
AC:149565
Hom:43332
AN:264690
ALFA (dbGaP/dbSNP Allele Frequency Aggregator)
AF: 0.532
AC:397835
Hom:108230
AN:747706
Local & regional cohorts 10 sources
ABraOM SABE-WGS-1171
AF: 0.544
AC:1273
Hom:346
AN:2342
ChinaMAP Phase 1
AF: 0.590
Denmark Genome
AF: 0.473
AC:142
AN:300
GenomeAsia100K
AF: 0.572
AC:1990
AN:3478
Korea4K (4,157 Koreans)
AF: 0.671
AC:4853
AN:7234
Qatari Genome
AF: 0.489
AC:86
AN:176
ToMMo 61KJPN (+60KJPN MNV)
AF: 0.739
AC:90735
Hom:33572
AN:122744
Turkish Variome
AF: 0.455
AC:701
Hom:152
AN:1542
UK10K
AF: 0.529
AC:3997
AN:7562
WBBC (Westlake BioBank for Chinese) pilot
AF: 0.596
AC:5338
Hom:1594
AN:8960
Showing 14 sources

ClinVar

Not reported in ClinVar

Computational Scores

AlphaGenome AVI
Benign1.1
BayesDel_noAF
Benign-0.93
CADD
Benign1.1
DANN
Benign0.43
GPN-Star LLR
N/A4.4
GPN-Star score
N/A-0.11
PhyloP100
Benign-0.16
Showing 7 of 7 scores

Splicing Scores

No splicing scores have been computed for this variant.

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

MaveDB functional evidence

MaveDB is a public repository of laboratory assays that test the effect of thousands of variants at once — treat this as supporting research data and interpret it with great caution; it is not a clinical classification.

No MaveDB functional evidence found for this variant.

Publications

Other links and lift over

For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.